Literature DB >> 17079374

Metal-on-metal hip resurfacing in osteonecrosis of the femoral head.

Matthew P Revell, Callum W McBryde, Sharad Bhatnagar, Paul B Pynsent, Ronan B C Treacy.   

Abstract

BACKGROUND: The treatment of end-stage osteonecrosis of the femoral head remains a challenge to the orthopaedic surgeon. Historically, total hip arthroplasty for this condition has been associated with poor rates of survival and function when compared with total hip arthroplasty for the treatment of osteoarthritis. The purpose of this study was to determine the medium-term clinical and radiographic results of metal-on-metal hip resurfacing arthroplasty in patients with end-stage osteonecrosis of the femoral head.
METHODS: From June 1994 to March 2004, a consecutive single-surgeon series of seventy-three hip resurfacing procedures were performed in sixty patients for the treatment of end-stage osteonecrosis of the femoral head. The cohort included forty-two men (ten of whom had a bilateral resurfacing) and eighteen women (three of whom had a bilateral resurfacing). The mean age was forty-three years (range, seventeen to sixty-nine years). A clinical and radiographic review was performed.
RESULTS: There were four revision operations and one planned revision of the seventy-three hips during the follow-up period. Two of these revisions were necessitated by aseptic failure of the femoral component. This represents an overall survival rate of 93.2% at a mean of 6.1 years of follow-up (range, two to twelve years).
CONCLUSIONS: On the basis of this study, metal-on-metal resurfacing of the hip for osteonecrosis can be considered a safe and effective form of surgery for this group of patients. Longer-term follow-up is required to confirm the expected continued success of this form of arthroplasty in this difficult-to-treat population. LEVEL OF EVIDENCE: Therapeutic Level IV. See Instructions to Authors on jbjs.org for a complete description of levels of evidence.

Entities:  

Mesh:

Year:  2006        PMID: 17079374     DOI: 10.2106/JBJS.F.01070

Source DB:  PubMed          Journal:  J Bone Joint Surg Am        ISSN: 0021-9355            Impact factor:   5.284


  17 in total

1.  Hip resurfacing in patients who have osteonecrosis and are 25 years or under.

Authors:  Siraj A Sayeed; Aaron J Johnson; D Alex Stroh; Thomas P Gross; Michael A Mont
Journal:  Clin Orthop Relat Res       Date:  2011-06       Impact factor: 4.176

2.  The influence of surgical approach on outcome in Birmingham hip resurfacing.

Authors:  Callum W McBryde; Matthew P Revell; Andrew M Thomas; Ronan B Treacy; Paul B Pynsent
Journal:  Clin Orthop Relat Res       Date:  2008-01-26       Impact factor: 4.176

Review 3.  [Revision surgery of hip resurfacing].

Authors:  K-P Günther; W-C Witzleb; M Stiehler; S Kirschner
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

4.  Hip resurfacing results for osteonecrosis are as good as for other etiologies at 2 to 12 years.

Authors:  Harlan C Amstutz; Michel J Le Duff
Journal:  Clin Orthop Relat Res       Date:  2009-09-12       Impact factor: 4.176

Review 5.  [Results of 5 to 10-year follow-up after hip resurfacing. A systematic analysis of the literature on long-term results].

Authors:  M C M Klotz; S J Breusch; M Hassenpflug; R G Bitsch
Journal:  Orthopade       Date:  2012-06       Impact factor: 1.087

6.  Survivorship and clinical outcome of Birmingham hip resurfacing: a minimum ten years' follow-up.

Authors:  Md Quamar Azam; Stephen McMahon; Gabrielle Hawdon; Sukesh Rao Sankineani
Journal:  Int Orthop       Date:  2015-03-31       Impact factor: 3.075

7.  Outcome of primary resurfacing hip replacement: evaluation of risk factors for early revision.

Authors:  Gareth H Prosser; Piers J Yates; David J Wood; Stephen E Graves; Richard N de Steiger; Lisa N Miller
Journal:  Acta Orthop       Date:  2010-02       Impact factor: 3.717

Review 8.  [Resurfacing for osteonecrosis of the femoral head].

Authors:  M Akbar; M A Mont; C Heisel; D R Marker; S D Ulrich; T M Seyler
Journal:  Orthopade       Date:  2008-07       Impact factor: 1.087

9.  Does the extent of osteonecrosis affect the survival of hip resurfacing?

Authors:  Satoshi Nakasone; Masaki Takao; Takashi Sakai; Takashi Nishii; Nobuhiko Sugano
Journal:  Clin Orthop Relat Res       Date:  2013-02-09       Impact factor: 4.176

10.  Initial American experience with hip resurfacing following FDA approval.

Authors:  Craig J Della Valle; Ryan M Nunley; Stephen J Raterman; Robert L Barrack
Journal:  Clin Orthop Relat Res       Date:  2008-10-24       Impact factor: 4.176

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.